Company Filing History:
Years Active: 2020
Title: Max Sauter: Innovator in Liposomal Compositions
Introduction
Max Sauter is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical delivery systems, particularly through his innovative work on liposomal compositions. His research focuses on enhancing the oral delivery of macromolecules, which has important implications for therapeutic and diagnostic applications.
Latest Patents
Max Sauter holds a patent for "Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules." This invention relates to liposomal compositions that incorporate tetraether lipids (TELs) and cell penetrating peptides (CPPs). The CPPs are attached to a compound that is part of the liposome's lipid double layer. This innovative approach aims to improve the oral delivery of therapeutic and diagnostic agents, making it a valuable advancement in the field.
Career Highlights
Max Sauter is affiliated with Heidelberg University, where he continues to engage in cutting-edge research. His work has garnered attention for its potential to revolutionize how macromolecules are delivered in medical treatments. With a focus on practical applications, Sauter’s contributions are paving the way for new therapeutic strategies.
Collaborations
Throughout his career, Max Sauter has collaborated with notable colleagues, including Philipp Uhl and Uwe Haberkorn. These partnerships have enriched his research and expanded the impact of his innovations in the scientific community.
Conclusion
Max Sauter is a key figure in the development of advanced liposomal compositions for drug delivery. His patent and ongoing research hold promise for improving therapeutic outcomes in medicine.